Advertisement
Screener

GREENLAND MINES LTD (GRML) Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

GREENLAND MINES LTD Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

GREENLAND MINES LTD (GRML) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of $2.21 million for the 12-month period ending 2025-12-31, per its 10-K/A filed 2026-08-14.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-08-14

  • GREENLAND MINES LTD effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2025 was $2.21M, a 71.44% increase from fiscal 2024.
  • GREENLAND MINES LTD effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2024 was $1.29M, a 558.44% increase from fiscal 2023.
  • GREENLAND MINES LTD effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2023 was $196.12K, a 74.89% increase from fiscal 2022.
  • GREENLAND MINES LTD effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2022 was $112.14K.
Period endEffective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 12 month
2025-12-31$2.21M
10-K/A · filed 2026-08-14
2024-12-31$1.29M
10-K/A · filed 2026-08-14
2023-12-31$196.12K
10-K · filed 2024-04-17
2022-12-31$112.14K
10-K · filed 2024-04-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43